Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:936

Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Sanofi is a diversified healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company operates its business in three broad categories, namely, Pharmaceuticals, Vaccines and Animal Health. The Pharmaceutic
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Sanofi is a diversified healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company operates its business in three broad categories, namely, Pharmaceuticals, Vaccines and Animal Health. The Pharmaceutical segment of the company focuses on the development of products in the areas of cardiovascular diseases, thrombosis, diabetes, central nervous system (CNS), internal medicine and cancer. Sanofi offers Vaccines such as pediatric combinations and poliomyelitis vaccines, influenza, adult and adolescent booster, meningitis and travel, endemic and measles, mumps and rubella (MMR).

Sanofi Key Recent Developments

Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products
Feb 19, 2013: Sanofi India May Launch Sub-brands Of Its Flagship OTC Products
Feb 15, 2013: Andhra Pradesh High Court Issues Ruling In Favor Of Sanofi-Aventis In Double Tax Case
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities
Feb 07, 2013: Sanofi Reports Revenue Of €8.53 Billion In Q4 2012GDPH3811FSA

This comprehensive SWOT profile of Sanofi provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 6
Sanofi - Key Facts 6
Sanofi - Key Employees 7
Sanofi - Key Employee Biographies 11
Sanofi - Major Products and Services 12
Sanofi - Pharmaceutical Pipeline Products Data 14
Sanofi, Pipeline Products by Therapy Area 14
Sanofi, Pipeline Products by Development Phase 15
Sanofi - Medical Equipment Pipeline Products Data 23
Sanofi Pipeline Products by Equipment Type 23
Sanofi Pipeline Products by Development Stage 25
Sanofi - History 27
Sanofi - Company Statement 35
Sanofi - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Sanofi - Key Manufacturing Facilities 51
Affiliate 51
Joint Venture 52
Section 2 – Company Analysis 53
Sanofi - Business Description 53
Sanofi - Corporate Strategy 55
Sanofi - SWOT Analysis 56
SWOT Analysis - Overview 56
Sanofi - Strengths 56
Strength - Broad Product Portfolio 56
Strength - Strong Research and Development Activities 56
Strength - Geographical Diversification 57
Sanofi - Weaknesses 57
Weakness - Reliance on Third Parties 57
Weakness - Product Recalls 57
Weakness - Discontinuation of Late Phase Projects 57
Weakness - Payouts to Settle Allegations 57
Sanofi - Opportunities 58
Opportunity - Inorganic Growth Drivers: Acquisitions 58
Opportunity - Strategic Agreements 58
Opportunity - Product Approvals and Launches 58
Opportunity - Strong Product Pipeline 59
Sanofi - Threats 59
Threat - Competitive Landscape 59
Threat - Stringent Government Regulations 59
Threat - Uncertain R&D Outcomes 59
Threat - Growing Parallel Trade 60
Sanofi - Key Competitors 61
Section 3 – Company Financial Ratios 62
Financial Ratios - Capital Market Ratios 62
Financial Ratios - Annual Ratios 62
Performance Chart 64
Financial Performance 64
Financial Ratios - Interim Ratios 65
Financial Ratios - Ratio Charts 66
Section 4 – Company’s Lifesciences Financial Deals and Alliances 67
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 67
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 68
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013 69
Sanofi, Medical Equipment, Deals By Type, 2007 to YTD 2013 70
Sanofi, Recent Deals Summary 71
Section 5 – Company’s Recent Developments 72
Sanofi, Recent Developments 72
Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products 72
Feb 19, 2013: Sanofi India May Launch Sub-brands Of Its Flagship OTC Products 74
Feb 15, 2013: Andhra Pradesh High Court Issues Ruling In Favor Of Sanofi-Aventis In Double Tax Case 74
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities 74
Feb 07, 2013: Sanofi Reports Revenue Of €8.53 Billion In Q4 2012 75
Jan 27, 2013: Sanofi Launches Enterogermina For Treatment Of Gastrointestinal Disorders 77
Jan 16, 2013: DKSH Expands Partnership With Sanofi In Malaysia 77
Jan 08, 2013: Sanofi Provides Update On Its R&D Pipeline At JP Morgan Healthcare Conference 77
Jan 08, 2013: OctoPlus Signs Master Service Agreement With Sanofi 79
Dec 16, 2012: Sanofi Breaks Ground For New Facility In King Abdullah Economic City, Saudi Arabia 79
Section 6 – Appendix 80
Methodology 80
Ratio Definitions 80
About GlobalData 84
Contact Us 84
Disclaimer 84

List of Tables
Sanofi, Key Facts 6
Sanofi, Key Employees 7
Sanofi, Key Employees (cont..) 10
Sanofi, Key Employee Biographies 11
Sanofi, Major Products and Services 12
Sanofi, Number of Pipeline Products by Therapy Area 14
Sanofi, Number of Pipeline Products by Development Stage 15
Sanofi, Pipeline Products By Therapy Area and Development Phase 16
Sanofi Number of Pipeline Products by Equipment Type 23
Sanofi Pipeline Products by Equipment Type 24
Sanofi Number of Pipeline Products by Development Stage 25
Sanofi Pipeline Products by Development Stage 26
Sanofi, History 27
Sanofi, Other Locations 36
Sanofi, Subsidiaries 36
Sanofi, Key Manufacturing Facilities 51
Sanofi, Affiliate 51
Sanofi, Joint Venture 52
Sanofi, Key Competitors 61
Sanofi, Ratios based on current share price 62
Sanofi, Annual Ratios 62
Sanofi, Interim Ratios 65
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 67
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 68
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013 69
Sanofi, Medical Equipment, Deals By Type, 2007 to YTD 2013 70
Sanofi, Recent Deals Summary 71
Currency Codes 80
Capital Market Ratios 80
Equity Ratios 81
Profitability Ratios 81
Cost Ratios 82
Liquidity Ratios 82
Leverage Ratios 83
Efficiency Ratios 83

List of Figures
Sanofi, Pipeline Products by Therapy Area 14
Sanofi, Pipeline Products by Development Phase 15
Sanofi Pipeline Products by Equipment Type 23
Sanofi Pipeline Products by Development Stage 25
Sanofi, Performance Chart (2008 - 2012) 64
Sanofi, Ratio Charts 66
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 67
Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 68
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013 69
Sanofi, Medical Equipment, Deals by Type, 2007 to YTD 2013 70




...